Abstract
A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation. Resolution of lesions in computed tomography (CT) was observed in all five patients with a single cyst, whereas all cysts survived in three patients with multiple brain parasites. One-day praziquantel is a good regimen for patients with a single viable brain cysticercus but is poorly effective for multiple cysts.
Original language | English |
---|---|
Article number | 968 |
Pages (from-to) | 175-177 |
Number of pages | 3 |
Journal | Clinical Neurology and Neurosurgery |
Volume | 103 |
Issue number | 3 |
DOIs | |
State | Published - 2001 |
Externally published | Yes |
Bibliographical note
Funding Information:Partial support was received from grants number FD-R-001107 from the Food and Drug Administration, and U19-A145431 from NIAID/NIH (USA).
Keywords
- Cysticercosis
- Neurocysticercosis
- Praziquantel
- Taenia solium